Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jan;16(1):176-179.
doi: 10.1007/s13311-018-00700-5.

Herpes Infections and Dementia: Rebutting Alternative Fact

Richard Lathe  1 , Nian-Sheng Tzeng  2 , Ruth Itzhaki  3   4
Affiliations
Comment

Herpes Infections and Dementia: Rebutting Alternative Fact

Richard Lathe et al. Neurotherapeutics. 2019 Jan.

Abstract

Recent commentary in Neurotherapeutics by Nath critically addresses the earlier report by Tzeng et al. that aggressive antiviral treatment (AVT) against herpes simplex virus (HSV) was associated with a later decrease in the incidence of Alzheimer's disease (AD). Nath raises issues that we respond to: we point out that (i) the treated group (probably with severe infection) is likely to harbor genetic risk alleles that predispose to both AD and HSV infection-the potential treatment bias cited by Nath would support (rather than challenge) the preventive effect of AVT; (ii) HSV is well known to establish persistent infection in the brain; and (iii) current AVT compounds used to combat herpes viruses are highly specific for this class of viruses. Instead of "alternative fact," the findings of Tzeng et al. argue in favor of clinical trials of AVT in AD.

Keywords: APOE; Acyclovir; Alzheimer's disease; Herpes simplex virus.

PubMed Disclaimer

Comment on

References

    1. Nath A. Association of herpes viral infections, antiherpetic therapy, and dementia: real or alternative fact? Neurotherapeutics. 2018;15:415–416. doi: 10.1007/s13311-018-0625-4. - DOI - PMC - PubMed
    1. Tzeng N-S, Chung CH, Lin FH, et al. Antiherpetic medications and reduced risk of dementia in patients with herpes simplex virus infections – a nationwide population-based cohort study in Taiwan. Neurotherapeutics. 2018;15:417–429. doi: 10.1007/s13311-018-0611-x. - DOI - PMC - PubMed
    1. Itzhaki RF, Lathe R. Herpes viruses and senile dementia: first population evidence for a causal link. J. Alzheimers Dis. 2018;64:363–366. doi: 10.3233/JAD-180266. - DOI - PubMed
    1. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet. 1997;349:241–244. doi: 10.1016/S0140-6736(96)10149-5. - DOI - PubMed
    1. Burgos JS, Ramirez C, Sastre I, Bullido MJ, Valdivieso F. ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. Neuroreport. 2003;14:1825–1827. doi: 10.1097/00001756-200310060-00013. - DOI - PubMed

Substances